Vice President of Data Management, Biostatistics, and Statistical Programming at Lexitas Pharma Services
Richard C. Zink is Vice President of Data Management, Biostatistics, and Statistical Programming at Lexitas Pharma Services where he is tasked with developing in-house biostatistics and programming capabilities and leading both biostatistics and data management in the design and analysis of ophthalmology clinical trials on behalf of their clients. Prior to Lexitas, Richard spent 17 years in and around medical product development at a real-world data company where he led data management and statistics in the analysis and reporting of data derived from electronic medical records; a software company where he developed and supported platforms to analyze and visualize safety and data quality outcomes from clinical trials; and pharmaceutical companies where he served as lead statistician for numerous clinical trials.
Richard is the author of Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS, the co-editor of Modern Approaches to Clinical Trials Using SAS: Classical, Adaptive, and Bayesian Methods, and a contributor to six other books on statistical topics in clinical trials and clinical research. He holds a Ph.D. in Biostatistics from the University of North Carolina at Chapel Hill, where he serves as Adjunct Assistant Professor of Biostatistics. Richard was awarded the distinction of Fellow of the American Statistical Association in 2020.
By This Author
Modern Approaches to Clinical Trials Using SAS®: Classical, Adaptive, and Bayesian Methods
This book thoroughly covers several domains of modern clinical trial design: classical, group sequential, adaptive, and Bayesian methods that are applicable to and widely used in various phases of pharmaceutical development.
Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP® and SAS®
- Marie Gaudard is a consultant specializing in statistical training with the use of JMP. She is currently a statistical writer with the JMP documentation team
- Satish Garla is a former Analytical Consultant in Risk Practice at SAS.
- Sam Gardner is a Senior Research Scientist at Eli Lilly and Company where he is focusing on business analytics and using statistical modeling.